Sharon H. Giordano, MD, MPH, FASCO
Department of Breast Medical Oncology, Division of Cancer Medicine
Experience & Service
Institutional Committee Activities
reviewer, Data Science Faculty Recruitment Committee, 2025 - Present
Member, Research Enterprise Evolution Initiative--Clinical Research Optimization, 2025 - Present
Member, Advisory Committee, Prostate Center Demonstration Project, 2025 - Present
Member, Mendelsohn Award Review Committee, 2025 - Present
Member, Charles A. LeMaistre Outstanding Achievement Award in Cancer Selection Committee, 2024 - Present
Chair Elect, Committee of Chairs, 2024 - Present
Member, Academic Policy Council, 2024 - Present
Member, Priority Review Committee for Institutional Philanthropy (PRC), 2024 - Present
Member, Academic Mentoring Council (AMC), 2024 - Present
Member, Standing Committee on Faculty Awards, 2023 - Present
Internal Advisory Committee Member, Texas Health Equity Alliance for Breast Cancer (THEAL), 2023 - Present
Member, Academic Leadership Team Committee, 2023 - Present
Internal Advisory Board Member, Prostate Cancer SPORE, 2023 - Present
Member, Value Task Force, 2022 - 2022
Internal Advisory Board Member, Morgan Welch Inflammatory Breast Cancer Program, 2022 - Present
Member, Faculty Vitality Taskforce, 2019 - 2023
Member, Endowed Positions & Award Committee (EPAC), 2019 - 2022
Voting Rotating Member, Epidemiology Database Access Committee, 2018 - Present
Member, Radiation Oncology Division Head Search Committee, 2018 - 2019
Member, Department of Breast Medical Oncology Assistant Professor (Tenure Track) Search Committee, 2018 - 2022
Chair, Internal Advisory Board, U-HAND (University of Houston/MD Anderson Program to Reduce Cancer Disparities), 2017 - 2022
Advisory Committee Member, Susan G. Komen Training Program to Reduce Breast Cancer Disparities in Black and Hispanic Women, 2017 - 2020
Member, Vice Provost Population Science Advisory Council (VP-PSAC), 2017 - 2018
Member, Community of Chairs, 2017 - Present
Member, Community of Science Chairs, 2017 - Present
Co-Chair, Epidemiology Department Chair Search Committee, 2016 - 2018
Member, Breast Cancer Moonshot Scientific Advisory Board, 2016 - 2017
Co-Chair, Gastroenterology, Hepatology & Nutrition Department Chair Search Committee, 2016 - 2017
Member, UT Population Health Strategic Plan Steering Committee, 2016 - 2016
Member, Department of Health Disparities Research Faculty Search Committee, 2015 - 2017
Distinguished Judge, Cyrus Scholar Awards, The University of Texas MD Anderson Internal Medicine Research Committee, 2015 - 2016
Member, Breast Surgical Oncology Chair Search Committee, 2015 - 2016
Member, Clinical Effectiveness Subcommittee, 2014 - 2015
Member, Executives and Non-faculty Leaders Team, 2014 - 2015
Member, Faculty Diversity, Equity, and Inclusion Committee, 2014 - 2023
Member, Department of Pathology Chair Search Committee, 2014 - 2015
Reviewer, Population Science Abstracts, Trainee Research Day, 2014
Member, Department of Breast Medical Oncology Assistant Professor (Tenure Track) Search Committee, 2013 - 2015
Member, MINTOS Grant Review Committee, 2013 - 2013
Member, Center for Radiation Oncology Internal Advisory Board, 2013 - 2016
Executive Advisory Board, Cancer Prevention Research Training Program (CPRTP) Advisory Committee, 2013 - Present
Member, Institutional Research Executive Committee, 2013 - 2016
Member, Gynecologic Oncology and Reproductive Medicine Faculty Search Committee, 2013 - 2013
Executive Committee Member, Duncan Family Institute for Cancer Prevention and Risk Assessment, 2013 - Present
Member, Institute for Cancer Care Executive Committee, 2013 - 2017
Member, Institute for Cancer Care Innovation Leadership Committee, 2013 - 2017
Member, Institutional Review Board IV, 2012 - 2013
Chair, Department of Breast Medical Oncology Assistant Professor (Tenure Track) Search Committee, 2011 - 2012
Member, Division of Cancer Medicine Sixth Annual Faculty Recognition and Awards Program Review Board, 2011 - 2011
Chair, Department of Health Services Research Faculty Search Committee, 2011
Member, Department of Breast Medical Oncology Strategic Planning Committee, 2011 - 2012
Member, Health Services Research Chair Search Committee, 2010
Chair, Clinical Effectiveness Subcommittee-Breast Cancer, 2008
Faculty Member, Hematology/Oncology Fellowship Steering Committee, 2007 - 2012
Director, Educational & Training Program, Breast Medical Oncology, 2007 - 2012
Member, Department of General Internal Medicine Search Committee, 2007
Chair, Department of Breast Medical Oncology Concept and Protocol Review Committee, 2007 - 2008
Member, Breast Cancer Guideline Committee, 2007 - 2014
Member, Survivorship Clinical Research Work Group, 2007
Member, Clinical Safety and Effectiveness Committee, 2007
Member, Pharmacy and Therapeutics Committee, 2006 - 2007
Member, Women Faculty Salary Equity Study Group, 2006 - 2007
Vice-Chair, Department of Breast Medical Oncology Concept and Protocol Review Committee, 2006 - 2007
Committee Vice Chair, Institutional Review Board IV, 2005 - 2012
Member, Psychosocial, Behavioral, and Health Services Research Committee (PBHSRC), 2005 - 2007
Member, Institutional Review Board III, 2005 - 2012
Associate Member, Institutional Review Board II, 2005 - 2012
Associate Member, Institutional Review Board I, 2005 - 2012
Member, Breast Center FMEA Committee, 2005 - 2006
Alternate Member, Pharmacy and Therapeutics Committee, 2004 - 2006
Honors & Awards
| 2025 - Present | MD Anderson’s Celebration of Faculty Excellence, The University of Texas MD Anderson Cancer Center |
| 2024 | Hologic, Inc Endowed Women Who Conquer Cancer Mentorship Award, Conquer Cancer Foundation, American Society of Clinical Oncology |
| 2022 | President's Recognition of Faculty Excellence Award, Clinical Quality Improvement, The University of Texas MD Anderson Cancer Center |
| 2020 | Jack and Beverly Randall Excellence in Cancer Care Award, MD Anderson Cancer Center Jack and Beverly Randall Endowment |
| 2019 | President's Recognition of Faculty Excellence Award in Education & Mentorship Advancement, The University of Texas MD Anderson Cancer Center |
| 2019 | Excellence in LEADership Award, The University of Texas MD Anderson Cancer Center |
| 2017 | Fellow of the American Society of Clinical Oncology, American Society of Clinical Oncology |
| 2015 - 2025 | Komen Scholar |
| 2013 | UT Regents' Outstanding Teaching Award Nominee, MD Anderson Cancer Center |
| 2013 | The Teaching Department of the Year - Breast Medical Oncology, Division of Cancer Medicine, MD Anderson Cancer Center |
| 2012 - 2015 | Faculty Scholar Award, The University of Texas MD Anderson Cancer Center |
| 2011 | Division of Cancer Medicine Mentor of the Year, The University of Texas MD Anderson Cancer Center |
| 2010 | Division of Cancer Medicine Distinguished Alumnus Award, The University of Texas MD Anderson Cancer Center |
| 2009 - 2014 | American Cancer Society Research Scholar, American Cancer Society |
| 2009 | Faculty Educator of the Month - July, The University of Texas MD Anderson Cancer Center |
| 2009 | Gerald P. Bodey Award for Excellence in Education Nominee, The University of Texas MD Anderson Cancer Center |
| 2009 | Tracy Starr Breast Cancer Research Fund Award, Cleveland Foundation |
| 2007 | Fellow, Sealy Center on Aging, The University of Texas Medical Branch at Galveston |
| 2004 - 2009 | Recipient, NIH Loan Repayment Program, National Institutes of Health |
| 2002 - 2004 | Breast Medical Oncology Certificates of Appreciation: Highest Revenue per % Effort and Highest Number of RVUs per % Effort, The University of Texas MD Anderson Cancer Center |
| 2002 | M. D. Anderson Trainee Recognition Day Honorable Mention, The University of Texas MD Anderson Cancer Center |
| 2001 - 2002 | ASCO Merit Award Recipient, American Society of Clinical Oncology |
| 2001 | Outstanding New Student Award, UT School of Public Health |
| 1996 | Alpha Omega Alpha, Johns Hopkins University School of Medicine |
| 1991 | Graduated With Distinction in Biology and Summa Cum Laude, Yale University |
| 1990 | Outstanding Student in Organic Chemistry Laboratory, Yale University |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2022. Systemic Therapy for Early Breast Cancer. Invited. 2022 Comprehensive Board Review in Hematology and Medical Oncology. Houston, Texas, US.
- 2022. Introduction to Health Services Research. Invited. Monthly Abdominal Imaging Research Lecture Series (MARS). Houston, Texas, US.
- 2014. Breakthrough Houston College Prep Enrichment Program. Invited. MD Anderson Women Faculty Programs. Houston, Texas, US.
- 2014. Opportunities in Health Services Research. Invited. Clinical Research and Education Unit (CREU). Houston, Texas, US.
- 2014. Work Life Integration Seminar. Invited. Hematology and Medical Oncology Fellowship Program. Houston, Texas, US.
- 2014. Opportunities in Health Services Research. Invited. Cancer Prevention and Control Grand Rounds. Houston, Texas, US.
- 2013. Male Breast Cancer. Invited. The SCAR Project. Houston, Texas, US.
- 2013. Panel Discussion: Health Services Research: A New Horizon. Invited. Women Executives in Science & Healthcare. Houston, Texas, US.
- 2012. Breast Cancer: Progress Through Understanding. Invited. Inaugural Hope in Houston: Hot Pink Luncheon. Houston, Texas, US.
- 2012. Outcomes and Quality of Cancer Treatment in Cancer Survivors. Invited. Advances in Oncology Institutional Grand Rounds. Houston, Texas, US.
- 2011. Metastatic Breast Cancer. Invited. Hematology and Medical Oncology Fellowship Program. Houston, Texas, US.
- 2011. Metastatic Breast Cancer: HER2 Negative. Invited. Hematology and Medical Oncology Fellowship Program. Houston, Texas, US.
- 2011. Cardiac Toxicity in Breast Cancer Survivors. Invited. Grands Rounds. Houston, Texas, US.
- 2010. Potential Research Applications of Cancer Registry and Administrative Datasets. Invited. Health Services Research Journal Club. Houston, Texas, US.
- 2010. HSR Today at MD Anderson Cancer Center. Invited. Health Services Research Retreat. Houston, Texas, US.
- 2010. Potential Research Applications of Cancer Registry and Administrative Datasets. Invited. Division of Cancer Medicine Grand Rounds. Houston, Texas, US.
- 2009. Male Breast Cancer. Invited. Core Curriculum Lecture. Houston, Texas, US.
- 2009. Male Breast Cancer. Invited. Breast Cancer Nurses Lecture Series. Houston, Texas, US.
- 2009. Male Breast Cancer. Invited. Core Curriculum Lecture. Houston, Texas, US.
- 2009. Treatment Paradigm for Breast Cancer. Invited. The Gynecology Oncology Fellowship Program Education Conference. Houston, Texas, US.
- 2007. Breast Cancer in Men, The Surgical Breast Education Conference. Invited. The Surgical Oncology Fellowship and Breast Surgical Oncology Fellowship Program. Houston, Texas, US.
- 2007. Principles of Male Breast Cancer. Invited. Core Curriculum Lecture. Houston, Texas, US.
- 2006. Uses of SEER and SEER-Medicare Data in Cancer Research. Invited. Cancer Medicine Grand Rounds. Houston, Texas, US.
- 2006. Uses of SEER and SEER-Medicare Data in Cancer Research. Invited. Department of Internal Medicine Research Conference. Houston, Texas, US.
- 2005. Cardiac Morbidity of Adjuvant Radiotherapy (ART) in Patients with Early Stage Breast Cancer Poster Presentation. Invited. Houston, Texas, US.
- 2005. Diagnosis and Treatment of Primary Breast Cancer. Invited. 27th annual Pharmacy Symposium on Cancer Chemotherapy. Houston, Texas, US.
- 2004. Male Breast Cancer. Invited. Houston, Texas, US.
- 2004. Effects of Treatment and Survivorship of Advanced Breast Cancer. Invited. Grand Rounds and Alice Judkins Lectureship. Houston, Texas, US.
- 2003. Breast Cancer in Men. Invited. Grand Rounds. Houston, Texas, US.
Regional Presentations
- 2018. Toxicities of Breast Cancer Treatments. Invited. 2018 Scholar Breakfast. Plano, TX, US.
- 2015. Panel Discussion: Cancer Survivorship: Improving Care and Quality of Life. Invited. Fort Worth, TX, US.
- 2015. Toxicities of Breast Cancer Treatment. Invited. Fort Worth, TX, US.
- 2010. Use of SEER-Medicare Data in Cancer Treatment and Outcomes Research. Invited. Cancer Center Grand Rounds. Galveston, TX, US.
National Presentations
- 2024. Systemic Therapy for Breast Cancer. Invited. 2024 Comprehensive Board Review in Hematology and Medical Oncology, US.
- 2024. Assessing early and late toxicities of cancer treatment with registry-based data. Invited. UNC, NC, US.
- 2024. Assessing early and late toxicities of cancer treatment with registry-based data. Invited. Cancer Outcomes Research, NC, US.
- 2023. Male Breast Cancer. Invited, US.
- 2023. Male Patients With Breast Cancer: Special Considerations and Gender-Specific Concerns. Invited, US.
- 2023. Determinants of Health in the Marginalized: Mechanisms and Mediators. Conference. Chicago, IL, US.
- 2022. Systemic Therapy for Early Breast Cancer. Invited. 2022 Comprehensive Board Review in Hematology and Medical Oncology, US.
- 2021. Special Issues in Breast Cancer. Invited. 2021 Comprehensive Board Review in Hematology and Medical Oncology. Houston, TX, US.
- 2019. The Toll on Health Care Providers. Conference. San Antonio, TX, US.
- 2019. Male Breast Cancer. Invited. Current Controversies Meeting. Boston, MA, US.
- 2018. Session Chair. Conference. Spotlight Session: Quality of Life, Survivorship and Cost of Care. San Antonio, TX, US.
- 2018. Special Issues in Breast Cancer. Invited. 2018 Comprehensive Board Review in Hematology and Medical Oncology. Houston, TX, US.
- 2018. Highlights in Male Breast Cancer. Invited. 2018 Best of ASCO Puerto Rico. Puerto Rico, PR, US.
- 2018. Updates on HER2-Positive Breast Cancer Treatment. Invited. Orlando, FL, US.
- 2018. Toxicities of Breast Cancer Treatments. Invited. Susan G. Komen North Texas Breast Health Lecture Series. Plano, TX, US.
- 2017. Poster Discussant. Conference. Spotlight Session - Cost/Fertility Preservation/Male Breast Cancer. San Antonio, TX, US.
- 2016. Special Issues in Breast Cancer. Invited. 2016 Comprehensive Board Review in Hematology and Medical Oncology. Houston, TX, US.
- 2016. Discussant. Conference. Oral Abstract Session B Breakout 2: Science of Quality. Chicago, IL, US.
- 2015. Special Issues in Breast Cancer. Invited. 2015 Comprehensive Board Review in Hematology and Medical Oncology. Houston, TX, US.
- 2015. Overview of Comparative Effectiveness Research and Observational Study Design. Conference. Chicago, IL, US.
- 2015. Use of Registry and Administrative Data in Cancer Outcomes Research. Invited. San Juan, PR, US.
- 2015. Use of Registry and Administrative Data in Cancer Outcomes Research. Invited. University of Puerto Rico Medical Sciences Grand Rounds. San Juan, PR, US.
- 2015. Assessing Toxicity of Therapy with Administrative Data. Invited. Boston, MA, US.
- 2015. Assessing Toxicity of Therapy with Administrative Data. Invited. Dana-Farber Cancer Institute Breast Oncology Seminar. Boston, MA, US.
- 2014. Special Issues in Breast Cancer. Invited. 2014 Comprehensive Board Review in Hematology and Medical Oncology. Houston, TX, US.
- 2014. Long-Term Health Outcomes. Conference. 2014 Breast Cancer Symposium. San Francisco, CA, US.
- 2014. Scientific Discussant. Conference. Breast Cancer - HER2/ER Oral Abstract Session. Chicago, IL, US.
- 2013. Special Issues in Breast Cancer. Invited. 2013 Comprehensive Board Review in Hematology and Medical Oncology. Houston, TX, US.
- 2012. Special Issues in Breast Cancer. Invited. 2012 Comprehensive Board Review in Hematology and Medical Oncology. Houston, TX, US.
- 2012. Scientific Discussant. Conference. Health Services Research Poster Session. Chicago, IL, US.
- 2011. Special Issues in Breast Cancer. Invited. 2011 Comprehensive Board Review in Hematology and Medical Oncology. Houston, TX, US.
- 2010. Special Issues in Breast Cancer. Invited. 2010 Comprehensive Board Review in Hematology and Medical Oncology. Houston, TX, US.
- 2010. Impact of Comorbid Conditions on Breast Cancer Survivorship. Conference. Chicago, IL, US.
- 2010. Use of SEER-Medicare Data in Cancer Treatment and Outcomes Research. Invited. The University of Texas Medical Branch Cancer Center. Galveston, TX, US.
- 2009. Special Issues in Breast Cancer. Invited. 2009 Comprehensive Board Review in Hematology and Medical Oncology. Houston, TX, US.
- 2009. Current Update on Medical Oncology Approach to Common Malignancies: Breast Cancer - What the Surgeon Needs to Know. Invited. AO North America and AO Spine North America. Houston, TX, US.
- 2008. New Options for Metastatic Breast Cancer. Invited. Amarillo, TX, US.
- 2008. Expert Discussion of Breast Cancer Nursing Practice Patterns: Adjuvant Therapies. Invited. Seattle, WA, US.
- 2008. Risk and Prognostic Factors. Invited. Male Breast Cancer Meeting: A Multidisciplinary Scientific Update Meeting. Rockville, MD, US.
- 2008. Anthracyclines and HER2 Inhibitors: Benefits vs. Risks. Invited. Philadelphia, PA, US.
- 2008. Advanced Disease Therapy. Invited. Breast Cancer Highlights Meeting. Santa Monica, CA, US.
- 2008. Sequence of Treatment in Stage 4 Disease. Invited. 8th Annual Oncology Update: Advances and Controversies. Park City, UT, US.
- 2007. Update on the Treatment of Early Stage Breast Cancer. Invited. Santa Barbara, CA, US.
- 2007. Update on the Treatment of Metastatic Breast Cancer. Invited. Santa Barbara, CA, US.
- 2007. Treatment Patterns for Breast Cancer. Invited. CISNET Breast Mid-Year Meeting. Houston, TX, US.
- 2007. Treatment Options for Anthracycline and Taxane Refractory Metastatic Breast Cancer. Invited. Reality Hematology/Oncology Meeting. St. Louis, MO, US.
- 2007. Management of HER-2 Positive Metastatic Breast Cancer. Invited. Reality Hematology/Oncology Meeting. St. Louis, MO, US.
- 2007. Update from San Antonio Breast Cancer Symposium. Invited. Chicago, IL, US.
- 2007. Update from San Antonio Breast Cancer Symposium. Invited. San Francisco, CA, US.
- 2006. Inflammatory Breast Cancer. Invited. Boston, MA, US.
- 2006. Update on the Treatment of Early Stage Breast Cancer. Invited. Baton Rouge, LA, US.
- 2006. Update on the Management of Early Stage Breast Cancer. Invited. M. D. Anderson Physicians Network Second Annual Symposium. Kauai, HI, US.
- 2006. Role of Molecular Prognostic and Predictive Factors in Clinical Practice. Invited. M. D. Anderson Physicians Network Second Annual Symposium. Kauai, HI, US.
- 2006. Advances in the Management of HER-2 Overexpressing Breast Cancer. Invited. M. D. Anderson Physicians Network Second Annual Symposium. Kauai, HI, US.
- 2006. Update from San Antonio Breast Cancer Symposium. Invited. San Francisco, CA, US.
- 2005. Cardiac Toxicity. Invited. Boston, MA, US.
- 2005. Update from ASCO Annual Meeting. Invited. Rochester, NY, US.
- 2004. Breast Cancer in 2004: An Overview. Invited. Grand Rounds. Racine, WI, US.
- 2004. Special Issues in Breast Cancer. Invited. 2004 Comprehensive Board Review in Hematology and Medical Oncology. Houston, TX, US.
- 2004. Breast Cancer in 2004: An Overview. Invited. St. Mary's Medical Center. Racine, WI, US.
- 2004. Breast Cancer in Men. Invited. 9th Annual Oncology Conference. Lake Ozark, MO, US.
- 2003. Special Issues in Breast Cancer. Invited. 2003 Comprehensive Board Review in Hematology and Medical Oncology. Houston, TX, US.
International Presentations
- 2025. How to treat metastatic breast cancer in men?. Invited. MULTIDISCIPLINAR DE CÂNCER DE MAMA 2025, BR.
- 2025. Obesity, diet, physical activity, and GLP1 - GIP1 RA: What do we know today?. Invited. MULTIDISCIPLINAR DE CÂNCER DE MAMA 2025, BR.
- 2025. When to use anthracycline-taxane-based (neo)adjuvant chemotherapy in early luminal breast cancer?. Invited. MULTIDISCIPLINAR DE CÂNCER DE MAMA 2025, BR.
- 2023. Systemic Therapy for Male Breast Cancer. Invited. Brussels.
- 2021. Adjuvant Decision Making In the Era of Limited Nodal Information. Conference. Virtual Worldwide.
- 2021. Panel Discussant. Invited. Optimal Locoregional Therapy: Treating the Axilla In Women with Breast Cancer. Virtual Worldwide.
- 2019. Extrapolating Data From Clinical Trials As We Are Treating Patients in Real Life. Conference. Vienna.
- 2018. Update on the Use of Potentially Cardiotoxic Therapy for the Treatment of Breast Cancer. Invited. Naples.
- 2018. Using Cancer Registry and Administrative Data to Assess Risk of Cardiotoxicity in Patients with Breast Cancer. Invited. Naples.
- 2015. Toxicities of Breast Cancer Therapies. Invited. Breast Cancer Symposium. Paris.
- 2010. Male Breast Cancer. Invited. e-grandrounds. Houston, US.
- 2009. Update on National Comprehensive Cancer Network: Breast Cancer Registry and Guidelines. Invited. Osaka.
- 2008. Cardiac Toxicity of Anthracyclines. Invited. Paris.
- 2007. Long Term Toxicities of Breast Cancer Therapy. Invited. Second National Congress of Mastology. Cartagena.
- 2007. Adjuvant Therapy for Post-Menopausal Women with Breast Cancer. Invited. Second National Congress of Mastology. Cartagena.
- 2007. Survival Benefit of Screening Mammography. Invited. Second National Congress of Mastology. Cartagena.
- 2007. Update on Trastuzumab in the Treatment of Breast Cancer. Invited. Veracruz.
- 2007. Update on Trastuzumab in the Treatment of Breast Cancer. Invited. Tijuana.
- 2006. Cardiac Toxicity of Adjuvant Anthracyclines Among Older Women with Breast Cancer. Invited. London, GB.
Grant & Contract Support
| Date: | 2026 - 2031 |
| Title: | A gene isoform-based tool to predict breast cancer survival and recurrence across subtype through long-read RNA-sequencing and deep learning |
| Funding Source: | NIH |
| Role: | Co-I |
| ID: | FP00027459 |
| Date: | 2025 - 2028 |
| Title: | Precision breast cancer prognosis prediction using tumor isoform expression with multi-cohort validation, including a new Texas cohort |
| Funding Source: | CPRIT |
| Role: | Co-I |
| ID: | RP260328 |
| Date: | 2025 - 2030 |
| Title: | Intersecting Impacts of Social Vulnerability and Structural Healthcare Inequities on Rural Cancer Disparities |
| Funding Source: | CPRIT |
| Role: | Co-I |
| ID: | PAR-22-230/ R01 |
| Date: | 2025 - 2026 |
| Title: | Efforts to Increase Representation on Prostate Cancer Clinical Trials at LBJ Hospital |
| Funding Source: | VCU Massey Cancer Center |
| Role: | Mentor |
| ID: | FP00025784 |
| Date: | 2025 - 2030 |
| Title: | UPR/MDACC Partnership for Excellence in Cancer Research |
| Funding Source: | NCI |
| Role: | PI |
| Date: | 2025 - 2030 |
| Title: | Increasing Uptake of Germline Genetic Testing among Prostate Cancer Patients in a Diverse Safety Net Hospital |
| Funding Source: | CPRIT |
| Role: | Mentor |
| ID: | RP250475 |
| Date: | 2025 - Present |
| Title: | UTMB Women's health research scholars program |
| Funding Source: | Institutional Research Career Development Award (BIRCWH) |
| Role: | Mentor |
| Date: | 2025 - Present |
| Title: | Development of a Brief Positive Affect Treatment (PAT) for Caregivers of Patients with Advanced Cancer |
| Funding Source: | American Cancer Society |
| Role: | Mentor |
| ID: | FP00026762 |
| Date: | 2025 - 2026 |
| Title: | Impact of Centralization of Care and Rural Hospital Closures on Cancer Outcomes in Rural Texas |
| Funding Source: | CPRIT |
| Role: | PI |
| Date: | 2024 - 2025 |
| Title: | Cancer Care Delivery and Breast Cancer: Impact and Associated Factors |
| Funding Source: | Breast Cancer Research Foundation |
| Role: | Co-I |
| ID: | FP00022690 |
| Date: | 2024 - 2025 |
| Title: | Delays in Timely Initiation of Treatment for Men with Prostate Cancer In Botswana |
| Funding Source: | Young Investigator Award, ASCO |
| Role: | Mentor |
| Date: | 2024 - 2026 |
| Title: | Robert A. Winn Diversity In Clinical Trials: Career Development Award |
| Funding Source: | Robert Winn Diversity in Clinical Trials Program |
| Role: | Mentor |
| Date: | 2024 - 2025 |
| Title: | Disparities in Guideline Concordant BRCA Testing for Medicare Advantage versus Traditional Medicare Beneficiaries with Breast, Ovarian, Pancreatic, and Prostate Cancers |
| Funding Source: | Young Investigator Award, ASCO |
| Role: | Mentor |
| Date: | 2023 - 2028 |
| Title: | Methods Training for Comparative Effectiveness Research in Cancer |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | R25CA257883 |
| Date: | 2022 - 2023 |
| Title: | Treatment Non-Completion Among Patients with Breast Cancer: Impact and Associated Factors |
| Funding Source: | Breast Cancer Research Foundation (BCRF) |
| Role: | Collaborator |
| ID: | BCRF-22-190 |
| Date: | 2022 - 2023 |
| Title: | Disparities in Adherence to Oral Anticancer Medications and Specialty Pharmacy Use |
| Funding Source: | Young Investigator Award, ASCO |
| Role: | Mentor |
| Date: | 2022 - 2027 |
| Title: | Skin Cancer Risks and Risk Prediction in Patients with Actinic Keratosis |
| Funding Source: | NIH/NCI |
| Role: | Mentor |
| ID: | 1K08CA263298-01A1 |
| Date: | 2022 - 2025 |
| Title: | Breast Cancer Treatment Initiation and Completion |
| Funding Source: | Komen Scholars |
| Role: | Collaborator |
| ID: | SAC220221 |
| Date: | 2021 - 2026 |
| Title: | Training Academic Gynecologic Oncologists |
| Funding Source: | NIH/NCI |
| Role: | Mentor |
| Date: | 2021 - 2026 |
| Title: | Data Management and Analysis Core for Comparative Effectiveness Research on Cancer in Texas |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Co-I |
| ID: | RP210130 |
| Date: | 2021 - 2026 |
| Title: | Health Benefits of Writing Therapy Among Chinese Breast Cancer Survivors |
| Funding Source: | American Cancer Society (ACS) |
| Role: | Co-I |
| ID: | RSG-21-040-01-CPPB |
| Date: | 2021 - 2026 |
| Title: | Writing to Heal: A Culturally Based Brief Expressive Intervention for Chinese Immigrant Breast Cancer Survivors |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | R01CA248213 |
| Date: | 2021 - 2026 |
| Title: | Impact of Clonal Hematopoiesis Mutations on Toxicity and Outcomes Following Oncologic Therapy |
| Funding Source: | NIH/NCI |
| Role: | Mentor |
| ID: | K08CA263313 |
| Date: | 2021 - 2025 |
| Title: | Effects of Biologic and Targeted Therapies for Rheumatoid Arthritis on Cancer Outcomes |
| Funding Source: | NIH/NCI |
| Role: | Co-PI |
| ID: | R01AR078484 |
| Date: | 2019 - 2025 |
| Title: | UPR/MDACC: Partnership for Excellence in Cancer Research |
| Funding Source: | NIH/NCI |
| Role: | Contact-Principal Investigator |
| ID: | U54CA096300 |
| Date: | 2019 - 2024 |
| Title: | Developing a Decision Aid for Chemotherapy in Older Women with Early Stage Breast Cancer |
| Funding Source: | NIH/NCI |
| Role: | Mentor |
| ID: | K08CA241087 |
| Date: | 2018 - 2023 |
| Title: | Obstetrical and Oncological Outcomes Among Reproductive Age Women with Gynecological and Breast Cancer |
| Funding Source: | NIH/NCI |
| Role: | Mentor |
| ID: | K08 CA2334333 |
| Date: | 2018 - 2025 |
| Title: | Assess: A Novel Breast Cancer Decision Support Tool |
| Funding Source: | Susan G. Komen Breast Cancer Foundation |
| Role: | PI |
| ID: | OG180002 |
| Date: | 2018 - 2023 |
| Title: | Genetic Testing in Young Women for Cancer Prevention |
| Funding Source: | NIH/NCI |
| Role: | Mentoring advisory committee |
| ID: | K07 CA222343 |
| Date: | 2016 - 2017 |
| Title: | International Male Breast Cancer Program of EORTC/TBCRC/BIG/NABCG: Understanding the Biology for Improved Patient Care. In Search of Valuable Biomarkers |
| Funding Source: | Breast Cancer Research Foundation |
| Role: | Co-PI |
| Date: | 2016 - 2021 |
| Title: | Economic Strain and Resilience in Cancer Patients: Assessing Patient-Reported Measures of the Burdens of Treatment |
| Funding Source: | NIH/NCI |
| Role: | Mentor |
| ID: | 5 K07 CA211804 |
| Date: | 2016 - 2023 |
| Title: | Technology Diffusion in Cancer: Geographic Variations, Facilitators, Outcomes, and Costs |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | R01 CA207216-01 |
| Date: | 2016 - 2017 |
| Title: | CCSG Supplement: Health Assessment to Advance Cancer Prevention, Screening, and Control in the MD Anderson Catchment Area: The State of Texas |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | 3 P30 CA016672-41S6 |
| Date: | 2016 - 2022 |
| Title: | Comparative Effectiveness Research on Cancer in Texas (CERCIT) 2.0: Admin Core |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Co-PI |
| ID: | RP160674-Admin Core |
| Date: | 2016 - 2022 |
| Title: | Chemotherapy Treatment Choices in Older Patients with Cancer |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | PI |
| ID: | RP160674-P2 |
| Date: | 2016 - 2026 |
| Title: | Cancer Center Support Grant: Cancer Risks and Outcomes Program |
| Funding Source: | NIH/NCI |
| Role: | Co-Leader |
| ID: | P30CA016672 |
| Date: | 2016 - 2018 |
| Title: | Developing a Decision Aid for Adjuvant Chemotherapy in Elderly Women with Early Stage Breast Cancer |
| Funding Source: | The University of Texas MD Anderson Cancer Center |
| Role: | Co-I |
| Date: | 2016 - 2022 |
| Title: | Health Services Career Development: Improving Medical Decisions in Ovarian Cancer |
| Funding Source: | NIH/NCI |
| Role: | Mentor |
| ID: | K07 CA201013 |
| Date: | 2016 - 2018 |
| Title: | Economic Strain in Cancer Patients (Pilot Study) |
| Funding Source: | The University of Texas MD Anderson Cancer Center |
| Role: | Co-I |
| Date: | 2015 - 2025 |
| Title: | Toxicities of Breast Cancer Treatment |
| Funding Source: | Susan G. Komen Breast Cancer Foundation |
| Role: | PI |
| ID: | SAC150061 |
| Date: | 2015 - 2018 |
| Title: | Human Papillomavirus (HPV)-Associated Second Malignancies in Patients Who Receive Allogeneic Stem Cell Transplantation |
| Funding Source: | Duncan Family Institute |
| Role: | Collaborator |
| Date: | 2015 - 2016 |
| Title: | Trends, Utilization and Risk of Hospitalization, Toxicity and Outcomes Following Radiotherapy Compared to Other Primary Treatments for Prostate Cancer |
| Funding Source: | The Center for Radiation Oncology Research, The University of Texas MD Anderson Cancer Center |
| Role: | Mentor |
| Date: | 2014 - 2016 |
| Title: | International Male Breast Cancer Program EORTC/TBCRC/BIG/NABCG: Deeper Characterization by RNA Sequencing |
| Funding Source: | Breast Cancer Research Foundation |
| Role: | Co-PI |
| Date: | 2014 - 2019 |
| Title: | Methods for Training in Patient-Centered Cancer Outcomes Research |
| Funding Source: | Agency for Healthcare Research and Quality |
| Role: | Co-I |
| ID: | 1 R25 HS023214 |
| Date: | 2014 - 2015 |
| Title: | The Impact of Potentially Inappropriate Medication Prescribing in Elderly Cancer Patients Receiving Chemotherapy |
| Funding Source: | American Society of Clinical Oncology (ASCO) |
| Role: | Mentor |
| Date: | 2014 - 2018 |
| Title: | A Clinical and Biological Characterization of Male Breast Cancer: An International EORTC, BIG, and NABCG Intergroup Study |
| Funding Source: | Susan G. Komen Breast Cancer Foundation |
| Role: | PI |
| ID: | OGEORT1301 |
| Date: | 2014 - 2016 |
| Title: | Comparative Effectiveness Research on Cancer in Texas (CERCIT) |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Co-Administrative Leader |
| ID: | RP140020-AC |
| Date: | 2013 - 2016 |
| Title: | Creating a Core Data Resource for Health Services Research |
| Funding Source: | Duncan Family Institute |
| Role: | PI |
| Date: | 2013 - 2017 |
| Title: | Patient Care Outcome Research in the Elderly |
| Funding Source: | Agency for Healthcare Research and Quality |
| Role: | Co-I |
| ID: | 1 R24 HS022134-01 |
| Date: | 2012 - 2018 |
| Title: | Multimodal MRI Biomarker of Mild Cognitive Impairment in Breast Cancer |
| Funding Source: | NIH/NCI |
| Role: | Collaborator |
| ID: | 1R01NR014195 |
| Date: | 2012 - 2014 |
| Title: | Using Claims Data to Evaluate Radiation Therapy Utilization at the End of Life |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | 5 R21 CA164449-02 |
| Date: | 2011 - 2016 |
| Title: | Innovative Methods for Modeling Longitudinal Medical Costs |
| Funding Source: | Agency for Healthcare Research and Quality |
| Role: | Consult |
| ID: | R01 HS020263 |
| Date: | 2011 - 2013 |
| Title: | Technology Diffusion & Cost-Effectiveness of Mammography Screening in Older Women |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | 1 R21 CA165092-01 |
| Date: | 2010 - 2014 |
| Title: | Male Breast Cancer: Understanding the Biology for an Improved Patient Care |
| Funding Source: | Breast Cancer Research Foundation |
| Role: | Co-PI |
| Date: | 2010 - 2016 |
| Title: | Assessing the Quality of Cancer Treatment in Texas |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | PI |
| ID: | RP140020-P2 |
| Date: | 2010 - 2016 |
| Title: | CERCIT: Comparative Effectiveness Research on Cancer in Texas |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Co-I |
| ID: | RP101207 |
| Date: | 2010 - 2016 |
| Title: | Quality of Supportive Care of Texans with Cancer (Project 4) - Comparative Effectiveness Research on Cancer in Texas |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Co-I |
| ID: | RP140020-P4 |
| Date: | 2009 - 2013 |
| Title: | Monoclonal Antibodies in Cancer Care: Is Underinsurance an Access Barrier? |
| Funding Source: | DHHS/AHRQ |
| Role: | Co-I |
| ID: | 1-R02-HS018535-01 |
| Date: | 2009 - 2010 |
| Title: | Adherence Among Older Women with Breast Cancer |
| Funding Source: | NIH/NCI |
| Role: | PI |
| ID: | 3K07-CA109064-05 S1 |
| Date: | 2009 - 2014 |
| Title: | Off-Label Chemotherapy for Treatment of Cancer: Patterns, Predictors, Risks |
| Funding Source: | American Cancer Society (ACS) |
| Role: | PI |
| ID: | RSGI-09-149-01-CPHPS |
| Date: | 2009 - 2012 |
| Title: | Optimizing the Delivery of Lifestyle Interventions |
| Funding Source: | The University of Texas M. D. Anderson Cancer Center |
| Role: | Co-I |
| Date: | 2009 - 2012 |
| Title: | Tracy Starr Breast Cancer Research Fund Award |
| Funding Source: | Cleveland Foundation |
| Role: | PI |
| ID: | L2009-0053 |
| Date: | 2009 - 2011 |
| Title: | Take Heart: Exercise & Diet Intervention for Heart Failure in Cancer Survivors |
| Funding Source: | NIH/NCI |
| Role: | Other Significant Contributor |
| ID: | CA135016-01A1 |
| Date: | 2008 - 2010 |
| Title: | Association of Breast Cancer and Its Therapies with Fracture |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | R21-CA131643-01A1 |
| Date: | 2008 - 2023 |
| Title: | Training of Academic Surgical Oncologists |
| Funding Source: | NIH/NCI |
| Role: | Mentor |
| ID: | S T32 CA009599 |
| Date: | 2007 - 2010 |
| Title: | Disparities in Mammography Screening in the Rural South |
| Funding Source: | Susan G. Komen Breast Cancer Foundation |
| Role: | Co-I |
| ID: | DISP0707435 03 |
| Date: | 2007 - 2011 |
| Title: | Patterns of Care and Disparities in the Treatment of Early Breast Cancer |
| Funding Source: | Department of Defense |
| Role: | Mentor |
| ID: | W81XWH-07-1-0669 03 |
| Date: | 2007 - 2007 |
| Title: | Surviving Cancer: Healthcare and Information Needs |
| Funding Source: | Texas Medical Center Fleming and Davenport Award |
| Role: | Co-I |
| Date: | 2006 - 2010 |
| Title: | Late Consequences of Therapy in Breast Cancer Survivors |
| Funding Source: | Texas Federation of Business and Professional Women's Clubs |
| Role: | PI |
| Date: | 2006 - 2007 |
| Title: | Risk of AML after Adjuvant Therapy For Breast Cancer |
| Funding Source: | Young Investigator Award, ASCO |
| Role: | Mentor |
| Date: | 2005 - 2007 |
| Title: | Burden of Breast Cancer Related Lymphedema on Working American Families |
| Funding Source: | American Cancer Society (ACS) |
| Role: | Co-I |
| ID: | RSGTL-05-093-01-CPHP |
| Date: | 2004 - 2010 |
| Title: | Adherence Among Older Women with Breast Cancer |
| Funding Source: | NIH/NCI |
| Role: | PI |
| ID: | 1K07CA109064-05 |
Patient Reviews
CV information above last modified September 03, 2025